Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects

Blood

Volumn 113, Issue 11, 2009, Pages 2547-2556

  Uchida, Kanji ^a,b   Nakata, Koh ^c   Suzuki, Takuji ^a   Luisetti, Maurizio ^d   Watanabe, Masato ^c   Koch, Diana E ^a   Stevens, Carrie A ^e   Beck, David C ^a,e   Denson, Lee A ^f   Carey, Brenna C ^a   Keicho, Naoto ^g   Krischer, Jeffrey P ^h   Yamada, Yoshitsugu ^b   Trapnell, Bruce C ^a,e,f  

^a Cincinnati Children's Hospital Medical Center   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; IMMUNOGLOBULIN;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; FEMALE; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; LUNG ALVEOLUS PROTEINOSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PURIFICATION;

EID: 63849328934     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-155689     Document Type: Article

References (49)

1. Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1. Immunity. 2001; 15:557-567.
2. Hamilton JA, Anderson GP. GM-CSF Biology. Growth Factors. 2004;22:225-231.
3. Trapnell BC, Whitsett JA. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol. 2002;64:775-802.
4. Trapnell BC, Whitsett JA, Nakata K. Pulmonary Alveolar Proteinosis. N Engl J Med. 2003;349: 2527-2539.
5. Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med. 2007;356:567-579.
6. Ruef C, Coleman DL. Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev Infect Dis. 1990;12:41-62.
7. Huffman Reed JA, Rice WR, Zsengeller ZK, Wert SE, Dranoff G, Whitsett JA. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol. 1997;273:L715-725.
8. Freedman MH, Grunberger T, Correa P, Axelrad AA, Dube ID, Cohen A. Autocrine and paracrine growth control by granulocyte-monocyte colony- stimulating factor of acute lymphoblastic leukemia cells. Blood. 1993;81:3068-3075.
9. Yamaoka K, Otsuka T, Niiro H, et al. Activation of STAT5 by lipopolysaccharide through granulo- cyte-macrophage colony-stimulating factor production in human monocytes. J Immunol. 1998;160:838-845.
10. Graves V, Gabig T, McCarthy L, Strour EF, Leemhuis T, English D. Simultaneous mobilization of Mac-1 (CD11b/CD18) and formyl peptide chemoattractant receptors in human neutrophils.Blood. 1992;80:776-787.
11. Hansen G, Hercus TR, McClure BJ, et al. The structure of the GM-CSF receptor complex re-veals a distinct mode of cytokine receptor activation. Cell. 2008;134:496-507.
12. Guthridge MA, Powell JA, Barry EF, et al. Growth factor pleiotropy is controlled by a receptor Tyr/ Ser motif that acts as a binary switch. EMBO J. 2006;25:479-489.
13. Carraway MS, Ghio AJ, Carter JD, Piantadosi CA. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000;161:1294-1299.
14. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony- stimulating factor in pulmonary homeostasis. Science. 1994;264:713-716.
15. Stanley E, Lieschke GJ, Grail D, et al. Granulo- cyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hemato- poiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A. 1994;91:5592-5596.
16. Ikegami M, UedaT, Hull W, et al. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol. 1996;270:L650-658.
17. Seymour JF, Lieschke GJ, Grail D, Quilici C, Hodgson G, Dunn AR. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulo- cyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long- term survival. Blood. 1997;90:3037-3049.
18. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166:215-235.
19. Kitamura T, Tanaka N, Watanabe J, et al. Idio- pathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999;190:875-880.
20. Uchida K, Nakata K, Trapnell BC, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood. 2004;103:1089-1098.
21. Lang RA, Metcalf D, Cuthbertson RA, et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell. 1987;51:675-686.
22. Jang J, Lim DS, Choi YE, et al. MLN51 and GM- CSF involvement in the proliferation of fibroblast- like synoviocytes in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2006;8:R170.
23. McQualter JL, Darwiche R, Ewing C, et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med. 2001;194:873-882.
24. Hamilton JA. GM-CSF in inflammation and autoimmunity. Trends Immunol. 2002;23:403-408.
25. Svenson M, Hansen MB, Ross C, et al. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood. 1998;91:2054- 2061.
26. Bendtzen K, Svenson M, Hansen MB, et al. GM- CSF autoantibodies in pulmonary alveolar proteinosis. N Engl J Med. 2007;356:2001-2002.
27. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of autoimmune pulmonary alveolar proteinosis patients in Japan. Am J Re- spir Crit Care Med. 2008.
28. Kurdowska A, Miller EJ, Noble JM, et al. Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol. 1996;157:2699-2706.
29. Watanabe M, Uchida K, Nakagaki K, et al. Anti- cytokine autoantibodies are ubiquitous in healthy individuals. FEBS Lett. 2007;581:2017-2021.
30. KitamuraT, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000;162:658-662.
31. Seymour JF, Doyle I R, Nakata K, et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar pro- teinosis. Thorax. 2003;58:252-257.
32. Berclaz PY, Shibata Y, Whitsett JA, Trapnell BC. GM-CSF, via PU. 1, regulates alveolar macro- phage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung. Blood. 2002;100:4193-4200.
33. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrom- etrydata. Electrophoresis. 1999;20:3551-3567.
34. Mascot Search: Matrix Science Ltd.; 1997.
35. Steindl F, Armbruster C, Pierer K, Purtscher M, Katinger HW. A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples. J Immunol Methods. 1998;217:143-151.
36. Zsengeller Z, Otake K, Hossain SA, Berclaz PY, Trapnell BC. Internalization of adenovirus by alveolar macrophages initiates early proinflamma- tory signaling during acute respiratory tract infection. J Virol. 2000;74:9655-9667.
37. Berclaz PY, Zsengeller Z, Shibata Y, et al. Endo- cytic internalization of adenovirus, nonspecific phagocytosis, and cytoskeletal organization are coordinately regulated in alveolar macrophages by GM-CSF and PU. 1. J Immunol. 2002;169:6332-6342.
38. Gonzalez-Juarrero M, Hattle JM, Izzo A, et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacte-rium tuberculosis infection. J Leukoc Biol. 2005; 77:914-922.
39. Presneill JJ, Nakata K, Inoue Y, Seymour JF. Pulmonary alveolar proteinosis. Clin Chest Med. 2004;25:593-613, viii.
40. Meager A, Wadhwa M, Bird C, et al. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology. 1999;97:526-532.
41. Sayani F, Montero-Julian FA, Ranchin V, et al. Identification of the soluble granulocyte-macro- phage colony stimulating factor receptor protein in vivo. Blood. 2000;95:461-469.
42. Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, Anderson GP. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol. 2004;286:L877-885.
43. Ross C, Svenson M, Hansen MB, Vejlsgaard GL, Bendtzen K. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J Clin Invest. 1995;95:1974-1978.
44. Bendtzen K, Hansen MB, Ross C, Svenson M. High-avidity autoantibodies to cytokines. Immunol Today. 1998;19:209-211.
45. Metcalf D, Nicola NA, Mifsud S, Di Rago L. Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections. Blood. 1999;93:1579-1585.
46. Finkelman FD, Madden KB, Morris SC, et al. Anti- cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol. 1993;151:1235-1244.
47. Zaheer A, Zaheer S, Sahu SK, Yang B, Lim R. Reduced severity of experimental autoimmune encephalomyelitis in GMF-deficient mice. Neuro- chem Res. 2007;32:39-47.
48. Ponomarev ED, Shriver LP, Maresz K, Pedras-Vasconcelos J, Verthelyi D, Dittel BN. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomy- elitis. J Immunol. 2007;178:39-48.
49. Krinner EM, Raum T, Petsch S, et al. A human monoclonal IgG1 potently neutralizing the proinflammatory cytokine GM-CSF. Mol Immunol.2007;44:916-925.